Category: <span>Lung Institute at Baylor College of Medicine</span>

Category: Lung Institute at Baylor College of Medicine

Anetumab ravtansine, Baylor St. Luke’s Medical Center, Dr. David Sugarbaker, Lung Institute at Baylor College of Medicine, malignant pleural mesothelioma, Mesothelin, mesothelioma cancer, Mesothelioma News, Phase II clinical trial, Vinorelbine

Phase II Trial for New Mesothelioma Treatment Opens to Patients

 

A Phase II clinical trial testing a new treatment for mesothelioma is now open to patients at Baylor College of Medicine Treatment Center.